An immunotherapeutic treatment against flea allergy dermatitis in cats by co-immunization of DNA and protein vaccines. (Q52701779)

6 May 2018

title

An immunotherapeutic treatment against flea allergy dermatitis in cats by co-immunization of DNA and protein vaccines. (English)

1 reference

6 May 2018

0 references

1 reference

Jin Jin

1

1 reference

6 May 2018

Zheng Ding

2

1 reference

6 May 2018

Fengxia Meng

3

1 reference

6 May 2018

Qiyong Liu

4

1 reference

6 May 2018

Terry Ng

5

1 reference

6 May 2018

Yanxin Hu

6

1 reference

6 May 2018

Gan Zhao

7

1 reference

6 May 2018

Bing Zhai

8

1 reference

6 May 2018

Hsien-Jue Chu

9

1 reference

6 May 2018

Bin Wang

10

1 reference

6 May 2018

language of work or name

English

0 references

publication date

1 February 2010

1 reference

6 May 2018

published in

Vaccine

1 reference

6 May 2018

volume

28

1 reference

6 May 2018

issue

8

1 reference

6 May 2018

page(s)

1997-2004

1 reference

6 May 2018

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

1 reference

Anaphylactic shock after insect-sting challenge in 138 persons with a previous insect-sting reaction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

Survey of flea infestation in dogs and cats in the United Kingdom during 2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

Immune response to fleas in a wild desert rodent: effect of parasite species, parasite burden, sex of host and host parasitological experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

Generation of Antigen-Specific Suppressor Cells during Allergy Desensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

Penicillin allergy and desensitization in serious infections during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

Opioid side effects--mechanism-based therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

Functional diversity of helper T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

The role of helper T cell products in mouse B cell differentiation and isotype regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

Type 1 T regulatory cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

Tai chi chuan exercise decreases A1C levels along with increase of regulatory T-cells and decrease of cytotoxic T-cell population in type 2 diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

Regulatory T-lymphocytes in asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

Treatment of autoimmune ovarian disease by co-administration with mouse zona pellucida protein 3 and DNA vaccine through induction of adaptive regulatory T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

Induction of adaptive T regulatory cells that suppress the allergic response by coimmunization of DNA and protein vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

Expression, purification from inclusion bodies, and crystal characterization of a transition state analog complex of arginine kinase: a model for studying phosphagen kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

The development of dermatitis infiltrated by gamma delta T cells in IL-7 transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

Vitiligo with inflammatory raised borders, associated with atopic dermatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

Chronic actinic dermatitis associated with adult T-cell leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

Differential diagnosis of IgE-mediated allergy in young children with wheezing or eczema symptoms using a single blood test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

The use of serum-specific IgE measurements for the diagnosis of peanut, tree nut, and seed allergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

FOXP3 promoter demethylation reveals the committed Treg population in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

The regulatory T cell family: distinct subsets and their interrelations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

CD4+CD25+Foxp3+ T cells and CD4+CD25-Foxp3+ T cells in aged mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

The immunopathogenesis of flea allergy dermatitis in dogs, an experimental study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

Late onset reactions to oral food challenge are linked to low serum interleukin-10 concentrations in patients with atopic dermatitis and food allergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

Cutting edge: the development of IL-4-producing B cells (B effector 2 cells) is controlled by IL-4, IL-4 receptor alpha, and Th2 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.092

10.1016/J.VACCINE.2009.10.092

7 January 2021

Identifiers

DOI

1 reference

6 May 2018

PubMed ID

20188255

1 reference

6 May 2018